Mati Therapeutics Inc. — Form D

Mati Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-15. The offering totals $10.0M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Robert Lee ButchofskyDirectorAustin, TX
Robert Lee ButchofskyExecutive OfficerAustin, TX
Deepank UtkhedeDirectorAustin, TX
Robert ButchofskyDirectorAustin, TX
Robert ButchofskyExecutive OfficerAustin, TX
Robert ButchofskyRelated PersonAustin, TX
Christopher MullerDirectorAustin, TX
Christopher MullerExecutive OfficerAustin, TX
Christopher MullerRelated PersonAustin, TX
Cameron NelsonExecutive OfficerAustin, TX
Cameron NelsonRelated PersonAustin, TX
Joseph Tortorice IIIDirectorAustin, TX
Joseph Tortorice IIIRelated PersonAustin, TX
Robert Lee Butchofsky IIDirectorAustin, TX
Robert Lee Butchofsky IIExecutive OfficerAustin, TX
Cameron Lee NelsonExecutive OfficerVancouver, A1
Christopher Lee MullerDirectorFoothill Ranch, CA
Christopher Lee MullerExecutive OfficerFoothill Ranch, CA
Deepank Lee UtkhedeDirectorSurrey, A1
Deepank Lee UtkhedeExecutive OfficerSurrey, A1
Ken JonesRelated PersonAustin, TX
Peter McDonnellRelated PersonAustin, TX
Jim MazzoRelated PersonAustin, TX
Deepank Lee UtkedeDirectorAustin, TX
Deepank Lee UtkedeExecutive OfficerAustin, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-02D/A$4.9M$2.6M
2025-10-08D$10.5M$9.9M
2025-09-23D$2.2M$2.2M
2019-05-24D$1.5M$165K
2018-10-16D$1.2M$50K
2014-10-10D$13.8M$150K

More